Key facts
- This page summarizes Martin Hendrix's Form 4 filing for Axcella Health Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 23 May 2022, 19:40.
Martin Hendrix - 19 May 2022 Form 4 Insider Report for Axcella Health Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 19 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 May 2022, 19:40:47 UTC
- Next SEC filing
- 19 May 2023
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ Paul Fehlner, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Martin Hendrix filed Form 4 for Axcella Health Inc. on 23 May 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXLA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +40,000
- Change %
- Price
- $0.000000
- Shares after
- 40,000
- Date
- 19 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 40,000
- Exercise price
- $1.70
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option shall vest and become exercisable in twelve equal quarterly installments following the grant date.